Turning innovation into better care
Everything you
need to know —
built for your practice.
The latest drugs, devices, guidelines and evidence — translated into clear, practical insights for physicians.
JUVMO™
tavapadon
FDA APPROVED
Once-daily D1/D5 agonist for Parkinson's disease
- 30-Second SummaryNew
- Clinical Evidence
- Dosing & Administration
- Safety Profile
- Access & Reimbursement
- Compare Treatments
Latest Updates
FDA approvalFirst selective D1/D5 dopamine agonist approved for Parkinson's disease.
Juvmo (tavapadon) · AbbVie
FDA De NovoFirst wearable sensor that tracks ketones and glucose together.
Libre Duo · Abbott
FDA approvalA second blood-based colorectal cancer screening test reaches the US market.
SimpleScreen CRC · Freenome
FDA De NovoThe first soft-tissue surgical robot with its arms built into the operating table.
OTTAVA Robotic Surgical System · Johnson & Johnson
FDA clearanceAI flags hidden structural heart disease from a routine 12-lead ECG.
EchoNext · Pathway Labs
FDA approvalA ctDNA test now selects bladder cancer patients for adjuvant immunotherapy.
Signatera CDx · Natera
FDA De NovoMachine-learning MRI aid helps tell MSA-P and PSP apart from Parkinson's.
neuropacs · Neuropacs
FDA premarket approvalThe first transcatheter valve with a dedicated aortic regurgitation indication.
Trilogy Transcatheter Heart Valve · JenaValve Technology
FDA approvalThe first oral peptide that blocks the IL-23 receptor, approved for plaque psoriasis.
Icotyde (icotrokinra) · Johnson & Johnson
FDA premarket approvalAn extended-depth-of-focus IOL with contrast comparable to a monofocal.
TECNIS PureSee IOL · Johnson & Johnson
FDA approvalrhBMP-2 bone graft is now approved for one- and two-level TLIF.
Infuse Bone Graft for TLIF · Medtronic
FDA premarket approvalA wearable Tumor Treating Fields device for locally advanced pancreatic cancer.
Optune Pax · Novocure
Featured Tools
View all- A1C CalculatorEstimate A1C reduction across treatments
- Risk CalculatorCardiovascular, renal and more
- Treatment ComparatorSide-by-side efficacy, safety and dosing
- Guideline NavigatorFind key recommendations by condition
- Reimbursement CheckCoverage, PA and coding information
- Clinical TrialsFind ongoing trials for your patients
Trending Topics
Global Regulatory Watch
View all
- FDAU.S.
- EMAEurope
- PMDAJapan
- NMPAChina
- TGAAustralia
Clinician Insights
Can we safely and effectively treat patients with severe aortic regurgitation with a transcatheter device? The answer is yes.”